Search Results

You are looking at 51 - 60 of 2,919 items for :

  • Refine by Access: All x
Clear All
Full access

Use of Inpatient Palliative Care Services in Patients With Advanced Cancer Receiving Critical Care Therapies

Kah Poh Loh, Maya Abdallah, Meng-Shiou Shieh, Mihaela S. Stefan, Penelope S. Pekow, Peter K. Lindenauer, Supriya G. Mohile, Dilip Babu, and Tara Lagu

prognoses of patients with advanced cancer admitted to the hospital. In this study of hospitalized patients with metastatic cancer who received CCTs, we investigated IPC use and described outcomes (including in-hospital mortality, LOS, discharge

Full access

Improving Care Coordination to Optimize Health Outcomes in Cancer Survivors

Linda Overholser and Carlin Callaway

Oncology, University of Colorado School of Medicine, who discussed the importance of care coordination to optimize health outcomes in cancer survivors at the NCCN 2019 Annual Conference, achieving coordinated, patient-centered care will require effective

Full access

Evaluation of AJCC and an Alternative Tumor Classification System for Primary Vulvar Squamous Cell Carcinoma

Sarah T. Le, Pritesh S. Karia, Beverley J. Vollenhoven, Robert J. Besaw, Colleen M. Feltmate, and Chrysalyne D. Schmults

-adjusted incidence of vSCC is 2.5 per 100,000 women. 3 The most significant prognostic factor for vSCC is lymph node status. 4 , 5 Other factors associated with poor outcomes include age, tumor diameter, tumor depth, tumor class, histologic grade, lymphovascular

Full access

Regional Variations in Clinical Trial Outcomes in Oncology

Brooke E. Wilson, Sallie-Anne Pearson, Michael B. Barton, and Eitan Amir

ability to test treatments across different populations with unique attributes, genetics, and ethnicity. When pooling outcomes across regions and countries, studies assume that treatment effects are similar. However, even among high-income countries with

Full access

Group Coping Intervention in Patients With Chronic Graft-Versus-Host Disease: A Pilot Randomized Clinical Trial

Ashley M. Nelson, Daniel Yang, Annemarie D. Jagielo, Jennifer D’Alotto, Cathleen Poliquin, Dustin J. Rabideau, Katherine G. Cronin, Richard A. Newcomb, Yi-Bin Chen, Zachariah DeFilipp, Joseph A. Greer, Areej El-Jawahri, and Lara Traeger

hypothesized that the Horizons Program would be feasible based on enrollment, attendance, and retention (primary outcomes). We also explored intervention effects on QoL, symptom burden, and anxiety and depression symptoms (secondary outcomes), as well as on

Full access

Pilot Trial of Streamlined Genetic Education and Traceback Genetic Testing in Prostate Cancer Survivors

Marc D. Schwartz, Beth N. Peshkin, Claudine Isaacs, Christopher Grisham, Nora J. Holmes, Lia J. Sorgen, Sean Collins, Nancy Dawson, Colleen McGuire, Tobechukwu Okobi, Kelsey Newell, Kavitha A. Kolla, and Veronique Weinstein

increase PCa risk up to 6-fold, are associated with poor disease outcomes, and are the most common PVs in individuals with PCa. 4 – 11 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for PCa recommend germline genetic testing for

Full access

Long-Term Outcomes of Myeloid Growth Factor Treatment

Gary H. Lyman and David C. Dale

M yeloid growth factors have been used for more than 20 years to ameliorate myelotoxicity after cancer chemotherapy and to prevent infections in patients with chronic neutropenia. Almost all data on long-term outcomes come from studies of

Full access

Compliance With Gastric Cancer Guidelines is Associated With Improved Outcomes

David J. Worhunsky, Yifei Ma, Yulia Zak, George A. Poultsides, Jeffrey A. Norton, Kim F. Rhoads, and Brendan C. Visser

National Surgical Quality Improvement Project (NSQIP). In general, each program follows the Donabedian 4 , 5 paradigm for measuring health care quality with respect to 1 of 3 domains: structure, process, and outcomes. Although limitations exist with each

Full access

Applying Quality Indicators to Examine Quality of Care During Active Surveillance in Low-Risk Prostate Cancer: A Population-Based Study

Narhari Timilshina, Antonio Finelli, George Tomlinson, Beate Sander, and Shabbir M.H. Alibhai

– 7 The foundation for quality assessment is based on the structure-process-outcomes paradigm by Donabedian. 8 – 11 The first quality indicators (QIs) for PC were developed more than a decade ago by investigators at RAND 12 – 16 and have

Full access

Impact of Chemotherapy Dose Intensity on Cancer Patient Outcomes

Gary H. Lyman

cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up . N Engl J Med 1995 ; 332 : 901 – 906 . 6 Budman DR Berry DA Cirrincione CT . Dose and dose intensity as determinants of outcome in